Castries, Saint Lucia. A Memorandum of Understanding (MOU) was signed between the Organisation of Eastern Caribbean States (OECS) and the Caribbean Public Health Agency (CARPHA) to strengthen procedures that ensure the safety, quality and efficacy of medicines in the region. Dr. Didacus Jules, Director General of the OECS and Dr. Joy St. John, Executive Director of CARPHA were both present for the official signing which took place on Thursday July 28th, 2022, at the OECS Commission in Castries, Saint Lucia. The MOU formalises a long- standing relationship between the OECS Pooled Procurement Service (PPS) and CARPHA.
 
The Medicines Quality Control and Surveillance Department (MQCSD) and the Caribbean Regulatory System (CRS) are the departments at CARPHA  responsible  for  providing  technical support for the procurement, testing, registration, and monitoring of medicines. The main aims of the agreement are to strengthen the approval processes of medicines procured through the OECS/PPS, by the CRS and to reaffirm the long-standing relationship with the MQCSD.
 
Speaking at the Ceremony Dr. Jules stated that the MOU further strengthens the already excellent working relationship between the two organisations that have a shared commitment to the needs of the region (OECS/Wider Caribbean) especially in healthcare delivery. According to Dr. Jules, ‘’The formalisation of this  relationship  with  an  MOU  will  strengthen  the  trust  of the Member States in the medicines used in  our  public  health  systems  within  Member  States of the OECS and CARPHA.  I  consider  the  relationship  with  CARPHA  and  the  OECS to  be  an exemplar  of  intra-regional collaboration that has evolved significantly since  the pandemic. We have walked every step of this perilous journey together, clasping hands tighter whenever the going went rougher.’’
 
In her remarks, Dr. St John stated that the agreement would strengthen the relationship between   the   two   agencies   by,   “supporting   and   improving   access   to   quality   assured medicines, and the monitoring of their safety, quality and efficacy in the OECS, other CARPHA Member  States and in the global community.” She noted the challenges that may    be faced by small markets like those in the Caribbean and commented that, “The OECS’ procurement service leads the Region in its approach to pooled procurement to optimise economies of scale to tackle this obstacle. To this end, CARPHA is pleased to strengthen this work at a technical level.” Dr. St John concluded by noting the unique nature of the collaboration,  giving  CARPHA’s  commitment  to  sustaining  the  partnership  and commending the relevant stakeholders for their contribution.